Rodin Gary, Mackay Jean A, Zimmermann Camilla, Mayer Carole, Howell Doris, Katz Mark, Sussman Jonathan, Brouwers Melissa
Department of Psychosocial Oncology and Palliative Care, Princess Margaret Hospital, University Health Network, 610 University Avenue, Toronto, ON M5G 2M9, Canada.
Support Care Cancer. 2009 Jun;17(6):627-44. doi: 10.1007/s00520-009-0601-y. Epub 2009 Mar 4.
The goal of this work was to identify methods of clinician-patient cancer-related communication that may impact patient outcomes associated with distress at critical points in the course of cancer care.
A systematic review of practice guidelines, systematic reviews, or randomized trials on this topic was conducted. Guidelines for quality was evaluated using the Appraisal of Guidelines for Research and Evaluation Instrument, and the contributive value for recommendations was assessed. Systematic reviews and randomized trials were also evaluated for methodological rigor.
Four existing guidelines, eight systematic reviews and nine randomized trials were identified. Two of the guidelines were of high quality, and all systematic reviews reported clear search criteria and support for their conclusions; the randomized trials were of modest or low quality. For all situations and disease stages, guidelines consistently identified open, honest, and timely communication as important; specifically, there was evidence for a reduction in anxiety when discussions of life expectancy and prognosis were included in consultations. Techniques to increase patient participation in decision-making were associated with greater satisfaction but did not necessarily decrease distress. Few studies took cultural and religious diversity into account.
There is little definitive evidence supporting the superiority of one specific method for communicating information compared to another. Evidence regarding the benefit of decision aids or other strategies to facilitate better communication is inconsistent. Since patients vary in their communication preferences and desire for active participation in decision making, there is a need to individualize communication style.
本研究的目的是确定临床医生与患者之间癌症相关沟通的方法,这些方法可能会影响癌症治疗过程中关键节点上与痛苦相关的患者预后。
对关于该主题的实践指南、系统评价或随机试验进行了系统综述。使用《研究与评价指南评估工具》对指南质量进行评估,并评估推荐意见的贡献价值。还对系统评价和随机试验的方法严谨性进行了评估。
共识别出四项现有指南、八项系统评价和九项随机试验。其中两项指南质量较高,所有系统评价均报告了明确的检索标准并为其结论提供了支持;随机试验质量中等或较低。对于所有情况和疾病阶段,指南一致认为开放、诚实和及时的沟通很重要;具体而言,有证据表明在会诊中纳入预期寿命和预后的讨论可减轻焦虑。增加患者参与决策的技巧与更高的满意度相关,但不一定能减轻痛苦。很少有研究考虑文化和宗教多样性。
几乎没有确凿证据支持一种特定信息沟通方法优于另一种方法。关于决策辅助工具或其他促进更好沟通的策略的益处的证据并不一致。由于患者在沟通偏好和积极参与决策的愿望方面存在差异,因此需要个性化沟通方式。